Noninvasive Ventilation Masks Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Noninvasive Ventilation Disposable Mask and Noninvasive Ventilation Reusable Mask), Application (Sleep Apnea, Chronic Obstructive Pulmonary Disease, Pneumonia, and Others), End User (Hospitals and Clinics, Home Care, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
The noninvasive ventilation masks market size is projected to reach US$ 3.25 billion by 2031 from US$ 2.05 billion in 2023. The market is expected to register a CAGR of 5.9% during 2023–2031.
Invasive ventilation methods are often avoided in COPD patients to reduce risks of complications such as infections and mechanical lung injuries. Noninvasive ventilation masks are preferred because they provide breathing support without requiring intubation.
A NIV reusable mask is a flexible and contoured device that covers a patient's nose and mouth and connects with a continuous positive airway pressure (CPAP) or bi-level positive airway pressure (BPAP) machine. This device supplies ambient air or a combination of medical oxygen (O2) and air at elevated pressure to the respiratory system for non-invasive positive pressure ventilation (NPPV). Various products such as PerformaTrak Reusable NIV Mask manufactured by Philips and NIV, non-vented, complete- NIV Face Mask by MSF International are commercially available NIV masks that can be reused during NIV therapy. These reusable NIV masks help healthcare facilities reduce the cost of consumables and provide non-invasive and comfortable ventilation to the patients.
Additionally, Air Liquide Medical Systems, a subsidiary of Air Liquide Healthcare operating in the noninvasive ventilation masks market, launched its ALNEST N1 Silent mask in May 2023. This product is integrated with Quiet Flow leak to ensure an optimal noise level and gent diffusion of the exhaled air. The company’s newly launched Alnest N1 Silent and Alnest N1 are reusable nasal masks with calibrated exhalation orifices. These NIV masks are designed for home or hospital use by patients (weighing more than 30 kg) who have been prescribed NPPV, such as CPAP or BiPAP therapy. The launch of products with advanced technology, such as Quiet Flow leak, Quiet Flow ventilation port, and innovative headgear, is expected to increase the demand for reusable NIV masks for NIV therapy.
The use of noninvasive ventilation has increased significantly and has become an integral tool in the management of acute and chronic respiratory failure in the home setting. NIV therapy in a homecare setting helps improve survival and quality of life for chronic stable hypercapnia. The patients recovering from acute respiratory failure associated with COPD are required to be evaluated for at least 2–4 weeks after resolution of respiratory acidosis. Thus, they can be provided with NIV at home. Also, stable COPD patients with chronic hypercapnic respiratory failure can benefit from home NIV. These aforementioned benefits drive the demand for NIV masks in home care settings.
The need for personalized NIV masks is widely recognized, and potential strategies are focused on the long-term use of these masks in patients in home settings. In March 2024, researchers from Imperial College London and Sheffield Children's Hospital received funding from children’s charity Action Medical Research and LifeArc, a charitable medical research organization, to develop a fully automated approach to creating customized NIV masks for children. This project will be carried out in partnership with companies such as Photocentric and Polymetrix. Such initiatives by research organizations are likely to bring opportunities for market players to attract new customers.
End User-Based Insights
Based on end user, the noninvasive ventilation masks market is segmented into hospitals and clinics, homecare, and others. The hospitals and clinics segment held the largest share in the noninvasive ventilation masks market in 2023 and is expected to register the highest CAGR in the market during 2023–2031. There has been an increase in medical costs over the last few decades with developments in healthcare technology. Development in hospital technologies, reforms in health insurance policies, economic growth of various regions, improved reimbursement programs, and various products and services provided are among the major reasons fueling the noninvasive ventilation masks market growth for the hospital and clinics segment. The growing number of hospitalizations due to increasing incidences of diseases such as asthma, COPD, and other chronic respiratory disorders, and the worldwide presence of hospitals such as Harefield Hospital, SingHealth Group of hospitals, and the Royal Gwent Hospital that provide NIV services also drive the market growth for the segment. The Royal Gwent Hospital, Newport, UK, has been providing NIV retrieval services (NRS) since 2017 with the aim of facilitating optimal management of patients requiring NIV therapy.
United Nation Department of Economic and Social Affairs, World Health Organization, Centers for Diseases Control and Prevention, Food and Drug Administration, and European Center for Disease Prevention and Control are among the primary and secondary sources referred to while preparing the noninvasive ventilation masks market report.
Invasive ventilation methods are often avoided in COPD patients to reduce risks of complications such as infections and mechanical lung injuries. Noninvasive ventilation masks are preferred because they provide breathing support without requiring intubation.
A NIV reusable mask is a flexible and contoured device that covers a patient's nose and mouth and connects with a continuous positive airway pressure (CPAP) or bi-level positive airway pressure (BPAP) machine. This device supplies ambient air or a combination of medical oxygen (O2) and air at elevated pressure to the respiratory system for non-invasive positive pressure ventilation (NPPV). Various products such as PerformaTrak Reusable NIV Mask manufactured by Philips and NIV, non-vented, complete- NIV Face Mask by MSF International are commercially available NIV masks that can be reused during NIV therapy. These reusable NIV masks help healthcare facilities reduce the cost of consumables and provide non-invasive and comfortable ventilation to the patients.
Additionally, Air Liquide Medical Systems, a subsidiary of Air Liquide Healthcare operating in the noninvasive ventilation masks market, launched its ALNEST N1 Silent mask in May 2023. This product is integrated with Quiet Flow leak to ensure an optimal noise level and gent diffusion of the exhaled air. The company’s newly launched Alnest N1 Silent and Alnest N1 are reusable nasal masks with calibrated exhalation orifices. These NIV masks are designed for home or hospital use by patients (weighing more than 30 kg) who have been prescribed NPPV, such as CPAP or BiPAP therapy. The launch of products with advanced technology, such as Quiet Flow leak, Quiet Flow ventilation port, and innovative headgear, is expected to increase the demand for reusable NIV masks for NIV therapy.
The use of noninvasive ventilation has increased significantly and has become an integral tool in the management of acute and chronic respiratory failure in the home setting. NIV therapy in a homecare setting helps improve survival and quality of life for chronic stable hypercapnia. The patients recovering from acute respiratory failure associated with COPD are required to be evaluated for at least 2–4 weeks after resolution of respiratory acidosis. Thus, they can be provided with NIV at home. Also, stable COPD patients with chronic hypercapnic respiratory failure can benefit from home NIV. These aforementioned benefits drive the demand for NIV masks in home care settings.
The need for personalized NIV masks is widely recognized, and potential strategies are focused on the long-term use of these masks in patients in home settings. In March 2024, researchers from Imperial College London and Sheffield Children's Hospital received funding from children’s charity Action Medical Research and LifeArc, a charitable medical research organization, to develop a fully automated approach to creating customized NIV masks for children. This project will be carried out in partnership with companies such as Photocentric and Polymetrix. Such initiatives by research organizations are likely to bring opportunities for market players to attract new customers.
End User-Based Insights
Based on end user, the noninvasive ventilation masks market is segmented into hospitals and clinics, homecare, and others. The hospitals and clinics segment held the largest share in the noninvasive ventilation masks market in 2023 and is expected to register the highest CAGR in the market during 2023–2031. There has been an increase in medical costs over the last few decades with developments in healthcare technology. Development in hospital technologies, reforms in health insurance policies, economic growth of various regions, improved reimbursement programs, and various products and services provided are among the major reasons fueling the noninvasive ventilation masks market growth for the hospital and clinics segment. The growing number of hospitalizations due to increasing incidences of diseases such as asthma, COPD, and other chronic respiratory disorders, and the worldwide presence of hospitals such as Harefield Hospital, SingHealth Group of hospitals, and the Royal Gwent Hospital that provide NIV services also drive the market growth for the segment. The Royal Gwent Hospital, Newport, UK, has been providing NIV retrieval services (NRS) since 2017 with the aim of facilitating optimal management of patients requiring NIV therapy.
United Nation Department of Economic and Social Affairs, World Health Organization, Centers for Diseases Control and Prevention, Food and Drug Administration, and European Center for Disease Prevention and Control are among the primary and secondary sources referred to while preparing the noninvasive ventilation masks market report.
1. INTRODUCTION
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. NONINVASIVE VENTILATION MASKS MARKET LANDSCAPE
4.1 PEST Analysis
5. NONINVASIVE VENTILATION MASKS MARKET – KEY MARKET DYNAMICS
5.1 Noninvasive Ventilation Masks Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Increasing Prevalence of Respiratory Diseases
5.2.2 Growing Inclination Toward Home Healthcare
5.3 Market Restraints
5.3.1 Side Effects Associated with NIV Masks
5.4 Market Opportunities
5.4.1 Increasing Adoption of NIV Masks
5.5 Future Trends
5.5.1 Rising Technological Advancements
5.6 Impact of Drivers and Restraints:
6. NONINVASIVE VENTILATION MASKS MARKET – GLOBAL MARKET ANALYSIS
6.1 Noninvasive Ventilation Masks Market Revenue (US$ Million), 2021–2031
6.2 Noninvasive Ventilation Masks Market Forecast Analysis
7. NONINVASIVE VENTILATION MASKS MARKET ANALYSIS – BY PRODUCT
7.1 Noninvasive Ventilation Disposable Mask
7.1.1 Overview
7.1.2 Noninvasive Ventilation Disposable Mask: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Noninvasive Ventilation Reusable Mask
7.2.1 Overview
7.2.2 Noninvasive Ventilation Reusable Mask: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
8. NONINVASIVE VENTILATION MASKS MARKET ANALYSIS – BY APPLICATION
8.1 Sleep Apnea
8.1.1 Overview
8.1.2 Sleep Apnea: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Chronic Obstructive Pulmonary Disease
8.2.1 Overview
8.2.2 Chronic Obstructive Pulmonary Disease: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Pneumonia
8.3.1 Overview
8.3.2 Pneumonia: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Others
8.4.1 Overview
8.4.2 Others: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
9. NONINVASIVE VENTILATION MASKS MARKET ANALYSIS – BY END USER
9.1 Hospitals and Clinics
9.1.1 Overview
9.1.2 Hospitals and Clinics: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Home Care
9.2.1 Overview
9.2.2 Home Care: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Others
9.3.1 Overview
9.3.2 Others: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10. NONINVASIVE VENTILATION MASKS MARKET – GEOGRAPHICAL ANALYSIS
10.1 Overview
10.2 North America
10.2.1 North America Noninvasive Ventilation Masks Market Overview
10.2.2 North America: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.2.3 North America: Noninvasive Ventilation Masks Market Breakdown, by Product
10.2.3.1 North America: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Product
10.2.4 North America: Noninvasive Ventilation Masks Market Breakdown, by Application
10.2.4.1 North America: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Application
10.2.5 North America: Noninvasive Ventilation Masks Market Breakdown, by End User
10.2.5.1 North America: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by End User
10.2.6 North America: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Country
10.2.6.1 North America: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Country
10.2.6.2 United States: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.2.6.2.1 United States: Noninvasive Ventilation Masks Market Breakdown, by Product
10.2.6.2.2 United States: Noninvasive Ventilation Masks Market Breakdown, by Application
10.2.6.2.3 United States: Noninvasive Ventilation Masks Market Breakdown, by End User
10.2.6.3 Canada: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.2.6.3.1 Canada: Noninvasive Ventilation Masks Market Breakdown, by Product
10.2.6.3.2 Canada: Noninvasive Ventilation Masks Market Breakdown, by Application
10.2.6.3.3 Canada: Noninvasive Ventilation Masks Market Breakdown, by End User
10.2.6.4 Mexico: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.2.6.4.1 Mexico: Noninvasive Ventilation Masks Market Breakdown, by Product
10.2.6.4.2 Mexico: Noninvasive Ventilation Masks Market Breakdown, by Application
10.2.6.4.3 Mexico: Noninvasive Ventilation Masks Market Breakdown, by End User
10.3 Europe
10.3.1 Europe Noninvasive Ventilation Masks Market Overview
10.3.2 Europe: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3 Europe: Noninvasive Ventilation Masks Market Breakdown, by Product
10.3.3.1 Europe: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Product
10.3.4 Europe: Noninvasive Ventilation Masks Market Breakdown, by Application
10.3.4.1 Europe: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Application
10.3.5 Europe: Noninvasive Ventilation Masks Market Breakdown, by End User
10.3.5.1 Europe: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by End User
10.3.6 Europe: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Country
10.3.6.1 Europe: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Country
10.3.6.2 United Kingdom: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.3.6.2.1 United Kingdom: Noninvasive Ventilation Masks Market Breakdown, by Product
10.3.6.2.2 United Kingdom: Noninvasive Ventilation Masks Market Breakdown, by Application
10.3.6.2.3 United Kingdom: Noninvasive Ventilation Masks Market Breakdown, by End User
10.3.6.3 Germany: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.3.6.3.1 Germany: Noninvasive Ventilation Masks Market Breakdown, by Product
10.3.6.3.2 Germany: Noninvasive Ventilation Masks Market Breakdown, by Application
10.3.6.3.3 Germany: Noninvasive Ventilation Masks Market Breakdown, by End User
10.3.6.4 France: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.3.6.4.1 France: Noninvasive Ventilation Masks Market Breakdown, by Product
10.3.6.4.2 France: Noninvasive Ventilation Masks Market Breakdown, by Application
10.3.6.4.3 France: Noninvasive Ventilation Masks Market Breakdown, by End User
10.3.6.5 Italy: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.3.6.5.1 Italy: Noninvasive Ventilation Masks Market Breakdown, by Product
10.3.6.5.2 Italy: Noninvasive Ventilation Masks Market Breakdown, by Application
10.3.6.5.3 Italy: Noninvasive Ventilation Masks Market Breakdown, by End User
10.3.6.6 Spain: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.3.6.6.1 Spain: Noninvasive Ventilation Masks Market Breakdown, by Product
10.3.6.6.2 Spain: Noninvasive Ventilation Masks Market Breakdown, by Application
10.3.6.6.3 Spain: Noninvasive Ventilation Masks Market Breakdown, by End User
10.3.6.7 Rest of Europe: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.3.6.7.1 Rest of Europe: Noninvasive Ventilation Masks Market Breakdown, by Product
10.3.6.7.2 Rest of Europe: Noninvasive Ventilation Masks Market Breakdown, by Application
10.3.6.7.3 Rest of Europe: Noninvasive Ventilation Masks Market Breakdown, by End User
10.4 Asia Pacific
10.4.1 Asia Pacific Noninvasive Ventilation Masks Market Overview
10.4.2 Asia Pacific: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.4.3 Asia Pacific: Noninvasive Ventilation Masks Market Breakdown, by Product
10.4.3.1 Asia Pacific: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Product
10.4.4 Asia Pacific: Noninvasive Ventilation Masks Market Breakdown, by Application
10.4.4.1 Asia Pacific: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Application
10.4.5 Asia Pacific: Noninvasive Ventilation Masks Market Breakdown, by End User
10.4.5.1 Asia Pacific: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by End User
10.4.6 Asia Pacific: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Country
10.4.6.1 Asia Pacific: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Country
10.4.6.2 China: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.4.6.2.1 China: Noninvasive Ventilation Masks Market Breakdown, by Product
10.4.6.2.2 China: Noninvasive Ventilation Masks Market Breakdown, by Application
10.4.6.2.3 China: Noninvasive Ventilation Masks Market Breakdown, by End User
10.4.6.3 Japan: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.4.6.3.1 Japan: Noninvasive Ventilation Masks Market Breakdown, by Product
10.4.6.3.2 Japan: Noninvasive Ventilation Masks Market Breakdown, by Application
10.4.6.3.3 Japan: Noninvasive Ventilation Masks Market Breakdown, by End User
10.4.6.4 India: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.4.6.4.1 India: Noninvasive Ventilation Masks Market Breakdown, by Product
10.4.6.4.2 India: Noninvasive Ventilation Masks Market Breakdown, by Application
10.4.6.4.3 India: Noninvasive Ventilation Masks Market Breakdown, by End User
10.4.6.5 Australia: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.4.6.5.1 Australia: Noninvasive Ventilation Masks Market Breakdown, by Product
10.4.6.5.2 Australia: Noninvasive Ventilation Masks Market Breakdown, by Application
10.4.6.5.3 Australia: Noninvasive Ventilation Masks Market Breakdown, by End User
10.4.6.6 South Korea: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.4.6.6.1 South Korea: Noninvasive Ventilation Masks Market Breakdown, by Product
10.4.6.6.2 South Korea: Noninvasive Ventilation Masks Market Breakdown, by Application
10.4.6.6.3 South Korea: Noninvasive Ventilation Masks Market Breakdown, by End User
10.4.6.7 Rest of APAC: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.4.6.7.1 Rest of APAC: Noninvasive Ventilation Masks Market Breakdown, by Product
10.4.6.7.2 Rest of APAC: Noninvasive Ventilation Masks Market Breakdown, by Application
10.4.6.7.3 Rest of APAC: Noninvasive Ventilation Masks Market Breakdown, by End User
10.5 Middle East and Africa
10.5.1 Middle East and Africa Noninvasive Ventilation Masks Market Overview
10.5.2 Middle East and Africa: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.5.3 Middle East and Africa: Noninvasive Ventilation Masks Market Breakdown, by Product
10.5.3.1 Middle East and Africa: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Product
10.5.4 Middle East and Africa: Noninvasive Ventilation Masks Market Breakdown, by Application
10.5.4.1 Middle East and Africa: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Application
10.5.5 Middle East and Africa: Noninvasive Ventilation Masks Market Breakdown, by End User
10.5.5.1 Middle East and Africa: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by End User
10.5.6 Middle East and Africa: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Country
10.5.6.1 Middle East and Africa: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Country
10.5.6.2 South Africa: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.5.6.2.1 South Africa: Noninvasive Ventilation Masks Market Breakdown, by Product
10.5.6.2.2 South Africa: Noninvasive Ventilation Masks Market Breakdown, by Application
10.5.6.2.3 South Africa: Noninvasive Ventilation Masks Market Breakdown, by End User
10.5.6.3 Saudi Arabia: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.5.6.3.1 Saudi Arabia: Noninvasive Ventilation Masks Market Breakdown, by Product
10.5.6.3.2 Saudi Arabia: Noninvasive Ventilation Masks Market Breakdown, by Application
10.5.6.3.3 Saudi Arabia: Noninvasive Ventilation Masks Market Breakdown, by End User
10.5.6.4 United Arab Emirates: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.5.6.4.1 United Arab Emirates: Noninvasive Ventilation Masks Market Breakdown, by Product
10.5.6.4.2 United Arab Emirates: Noninvasive Ventilation Masks Market Breakdown, by Application
10.5.6.4.3 United Arab Emirates: Noninvasive Ventilation Masks Market Breakdown, by End User
10.5.6.5 Rest of Middle East and Africa: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.5.6.5.1 Rest of Middle East and Africa: Noninvasive Ventilation Masks Market Breakdown, by Product
10.5.6.5.2 Rest of Middle East and Africa: Noninvasive Ventilation Masks Market Breakdown, by Application
10.5.6.5.3 Rest of Middle East and Africa: Noninvasive Ventilation Masks Market Breakdown, by End User
10.6 South and Central America
10.6.1 South and Central America Noninvasive Ventilation Masks Market Overview
10.6.2 South and Central America: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.6.3 South and Central America: Noninvasive Ventilation Masks Market Breakdown, by Product
10.6.3.1 South and Central America: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Product
10.6.4 South and Central America: Noninvasive Ventilation Masks Market Breakdown, by Application
10.6.4.1 South and Central America: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Application
10.6.5 South and Central America: Noninvasive Ventilation Masks Market Breakdown, by End User
10.6.5.1 South and Central America: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by End User
10.6.6 South and Central America: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Country
10.6.6.1 South and Central America: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Country
10.6.6.2 Brazil: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.6.6.2.1 Brazil: Noninvasive Ventilation Masks Market Breakdown, by Product
10.6.6.2.2 Brazil: Noninvasive Ventilation Masks Market Breakdown, by Application
10.6.6.2.3 Brazil: Noninvasive Ventilation Masks Market Breakdown, by End User
10.6.6.3 Argentina: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.6.6.3.1 Argentina: Noninvasive Ventilation Masks Market Breakdown, by Product
10.6.6.3.2 Argentina: Noninvasive Ventilation Masks Market Breakdown, by Application
10.6.6.3.3 Argentina: Noninvasive Ventilation Masks Market Breakdown, by End User
10.6.6.4 Rest of South and Central America: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.6.6.4.1 Rest of South and Central America: Noninvasive Ventilation Masks Market Breakdown, by Product
10.6.6.4.2 Rest of South and Central America: Noninvasive Ventilation Masks Market Breakdown, by Application
10.6.6.4.3 Rest of South and Central America: Noninvasive Ventilation Masks Market Breakdown, by End User
11. INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies in Noninvasive Ventilation Mask Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. COMPANY PROFILES
12.1 Hamilton Medical AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 ResMed Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Fisher & Paykel Healthcare Corp Ltd
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Air Liquide Medical Systems
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Dragerwerk AG & Co KGaA
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Intersurgical Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 BMC Medical Co Ltd
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 DeVilbiss Healthcare LLC
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Armstrong Medical Ltd
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Koninklijke Philips NV
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Besmed Health Business Corp
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
12.12 Sleepnet Corporation.
12.12.1 Key Facts
12.12.2 Business Description
12.12.3 Products and Services
12.12.4 Financial Overview
12.12.5 SWOT Analysis
12.12.6 Key Developments
12.13 SunMed Group Holdings LLC ( AirLife)
12.13.1 Key Facts
12.13.2 Business Description
12.13.3 Products and Services
12.13.4 Financial Overview
12.13.5 SWOT Analysis
12.13.6 Key Developments
12.14 Dimar S.P.A.
12.14.1 Key Facts
12.14.2 Business Description
12.14.3 Products and Services
12.14.4 Financial Overview
12.14.5 SWOT Analysis
12.14.6 Key Developments
12.15 Hangzhou Formed Medical Devices Co., Ltd
12.15.1 Key Facts
12.15.2 Business Description
12.15.3 Products and Services
12.15.4 Financial Overview
12.15.5 SWOT Analysis
12.15.6 Key Developments
12.16 SURU INTERNATIONAL PVT. LTD.
12.16.1 Key Facts
12.16.2 Business Description
12.16.3 Products and Services
12.16.4 Financial Overview
12.16.5 SWOT Analysis
12.16.6 Key Developments
12.17 Medline Industries LP
12.17.1 Key Facts
12.17.2 Business Description
12.17.3 Products and Services
12.17.4 Financial Overview
12.17.5 SWOT Analysis
12.17.6 Key Developments
13. APPENDIX
13.1 Glossary of Terms
13.2 About The Insight Partners
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. NONINVASIVE VENTILATION MASKS MARKET LANDSCAPE
4.1 PEST Analysis
5. NONINVASIVE VENTILATION MASKS MARKET – KEY MARKET DYNAMICS
5.1 Noninvasive Ventilation Masks Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Increasing Prevalence of Respiratory Diseases
5.2.2 Growing Inclination Toward Home Healthcare
5.3 Market Restraints
5.3.1 Side Effects Associated with NIV Masks
5.4 Market Opportunities
5.4.1 Increasing Adoption of NIV Masks
5.5 Future Trends
5.5.1 Rising Technological Advancements
5.6 Impact of Drivers and Restraints:
6. NONINVASIVE VENTILATION MASKS MARKET – GLOBAL MARKET ANALYSIS
6.1 Noninvasive Ventilation Masks Market Revenue (US$ Million), 2021–2031
6.2 Noninvasive Ventilation Masks Market Forecast Analysis
7. NONINVASIVE VENTILATION MASKS MARKET ANALYSIS – BY PRODUCT
7.1 Noninvasive Ventilation Disposable Mask
7.1.1 Overview
7.1.2 Noninvasive Ventilation Disposable Mask: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Noninvasive Ventilation Reusable Mask
7.2.1 Overview
7.2.2 Noninvasive Ventilation Reusable Mask: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
8. NONINVASIVE VENTILATION MASKS MARKET ANALYSIS – BY APPLICATION
8.1 Sleep Apnea
8.1.1 Overview
8.1.2 Sleep Apnea: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Chronic Obstructive Pulmonary Disease
8.2.1 Overview
8.2.2 Chronic Obstructive Pulmonary Disease: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Pneumonia
8.3.1 Overview
8.3.2 Pneumonia: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Others
8.4.1 Overview
8.4.2 Others: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
9. NONINVASIVE VENTILATION MASKS MARKET ANALYSIS – BY END USER
9.1 Hospitals and Clinics
9.1.1 Overview
9.1.2 Hospitals and Clinics: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Home Care
9.2.1 Overview
9.2.2 Home Care: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Others
9.3.1 Overview
9.3.2 Others: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10. NONINVASIVE VENTILATION MASKS MARKET – GEOGRAPHICAL ANALYSIS
10.1 Overview
10.2 North America
10.2.1 North America Noninvasive Ventilation Masks Market Overview
10.2.2 North America: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.2.3 North America: Noninvasive Ventilation Masks Market Breakdown, by Product
10.2.3.1 North America: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Product
10.2.4 North America: Noninvasive Ventilation Masks Market Breakdown, by Application
10.2.4.1 North America: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Application
10.2.5 North America: Noninvasive Ventilation Masks Market Breakdown, by End User
10.2.5.1 North America: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by End User
10.2.6 North America: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Country
10.2.6.1 North America: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Country
10.2.6.2 United States: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.2.6.2.1 United States: Noninvasive Ventilation Masks Market Breakdown, by Product
10.2.6.2.2 United States: Noninvasive Ventilation Masks Market Breakdown, by Application
10.2.6.2.3 United States: Noninvasive Ventilation Masks Market Breakdown, by End User
10.2.6.3 Canada: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.2.6.3.1 Canada: Noninvasive Ventilation Masks Market Breakdown, by Product
10.2.6.3.2 Canada: Noninvasive Ventilation Masks Market Breakdown, by Application
10.2.6.3.3 Canada: Noninvasive Ventilation Masks Market Breakdown, by End User
10.2.6.4 Mexico: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.2.6.4.1 Mexico: Noninvasive Ventilation Masks Market Breakdown, by Product
10.2.6.4.2 Mexico: Noninvasive Ventilation Masks Market Breakdown, by Application
10.2.6.4.3 Mexico: Noninvasive Ventilation Masks Market Breakdown, by End User
10.3 Europe
10.3.1 Europe Noninvasive Ventilation Masks Market Overview
10.3.2 Europe: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3 Europe: Noninvasive Ventilation Masks Market Breakdown, by Product
10.3.3.1 Europe: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Product
10.3.4 Europe: Noninvasive Ventilation Masks Market Breakdown, by Application
10.3.4.1 Europe: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Application
10.3.5 Europe: Noninvasive Ventilation Masks Market Breakdown, by End User
10.3.5.1 Europe: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by End User
10.3.6 Europe: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Country
10.3.6.1 Europe: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Country
10.3.6.2 United Kingdom: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.3.6.2.1 United Kingdom: Noninvasive Ventilation Masks Market Breakdown, by Product
10.3.6.2.2 United Kingdom: Noninvasive Ventilation Masks Market Breakdown, by Application
10.3.6.2.3 United Kingdom: Noninvasive Ventilation Masks Market Breakdown, by End User
10.3.6.3 Germany: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.3.6.3.1 Germany: Noninvasive Ventilation Masks Market Breakdown, by Product
10.3.6.3.2 Germany: Noninvasive Ventilation Masks Market Breakdown, by Application
10.3.6.3.3 Germany: Noninvasive Ventilation Masks Market Breakdown, by End User
10.3.6.4 France: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.3.6.4.1 France: Noninvasive Ventilation Masks Market Breakdown, by Product
10.3.6.4.2 France: Noninvasive Ventilation Masks Market Breakdown, by Application
10.3.6.4.3 France: Noninvasive Ventilation Masks Market Breakdown, by End User
10.3.6.5 Italy: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.3.6.5.1 Italy: Noninvasive Ventilation Masks Market Breakdown, by Product
10.3.6.5.2 Italy: Noninvasive Ventilation Masks Market Breakdown, by Application
10.3.6.5.3 Italy: Noninvasive Ventilation Masks Market Breakdown, by End User
10.3.6.6 Spain: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.3.6.6.1 Spain: Noninvasive Ventilation Masks Market Breakdown, by Product
10.3.6.6.2 Spain: Noninvasive Ventilation Masks Market Breakdown, by Application
10.3.6.6.3 Spain: Noninvasive Ventilation Masks Market Breakdown, by End User
10.3.6.7 Rest of Europe: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.3.6.7.1 Rest of Europe: Noninvasive Ventilation Masks Market Breakdown, by Product
10.3.6.7.2 Rest of Europe: Noninvasive Ventilation Masks Market Breakdown, by Application
10.3.6.7.3 Rest of Europe: Noninvasive Ventilation Masks Market Breakdown, by End User
10.4 Asia Pacific
10.4.1 Asia Pacific Noninvasive Ventilation Masks Market Overview
10.4.2 Asia Pacific: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.4.3 Asia Pacific: Noninvasive Ventilation Masks Market Breakdown, by Product
10.4.3.1 Asia Pacific: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Product
10.4.4 Asia Pacific: Noninvasive Ventilation Masks Market Breakdown, by Application
10.4.4.1 Asia Pacific: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Application
10.4.5 Asia Pacific: Noninvasive Ventilation Masks Market Breakdown, by End User
10.4.5.1 Asia Pacific: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by End User
10.4.6 Asia Pacific: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Country
10.4.6.1 Asia Pacific: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Country
10.4.6.2 China: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.4.6.2.1 China: Noninvasive Ventilation Masks Market Breakdown, by Product
10.4.6.2.2 China: Noninvasive Ventilation Masks Market Breakdown, by Application
10.4.6.2.3 China: Noninvasive Ventilation Masks Market Breakdown, by End User
10.4.6.3 Japan: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.4.6.3.1 Japan: Noninvasive Ventilation Masks Market Breakdown, by Product
10.4.6.3.2 Japan: Noninvasive Ventilation Masks Market Breakdown, by Application
10.4.6.3.3 Japan: Noninvasive Ventilation Masks Market Breakdown, by End User
10.4.6.4 India: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.4.6.4.1 India: Noninvasive Ventilation Masks Market Breakdown, by Product
10.4.6.4.2 India: Noninvasive Ventilation Masks Market Breakdown, by Application
10.4.6.4.3 India: Noninvasive Ventilation Masks Market Breakdown, by End User
10.4.6.5 Australia: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.4.6.5.1 Australia: Noninvasive Ventilation Masks Market Breakdown, by Product
10.4.6.5.2 Australia: Noninvasive Ventilation Masks Market Breakdown, by Application
10.4.6.5.3 Australia: Noninvasive Ventilation Masks Market Breakdown, by End User
10.4.6.6 South Korea: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.4.6.6.1 South Korea: Noninvasive Ventilation Masks Market Breakdown, by Product
10.4.6.6.2 South Korea: Noninvasive Ventilation Masks Market Breakdown, by Application
10.4.6.6.3 South Korea: Noninvasive Ventilation Masks Market Breakdown, by End User
10.4.6.7 Rest of APAC: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.4.6.7.1 Rest of APAC: Noninvasive Ventilation Masks Market Breakdown, by Product
10.4.6.7.2 Rest of APAC: Noninvasive Ventilation Masks Market Breakdown, by Application
10.4.6.7.3 Rest of APAC: Noninvasive Ventilation Masks Market Breakdown, by End User
10.5 Middle East and Africa
10.5.1 Middle East and Africa Noninvasive Ventilation Masks Market Overview
10.5.2 Middle East and Africa: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.5.3 Middle East and Africa: Noninvasive Ventilation Masks Market Breakdown, by Product
10.5.3.1 Middle East and Africa: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Product
10.5.4 Middle East and Africa: Noninvasive Ventilation Masks Market Breakdown, by Application
10.5.4.1 Middle East and Africa: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Application
10.5.5 Middle East and Africa: Noninvasive Ventilation Masks Market Breakdown, by End User
10.5.5.1 Middle East and Africa: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by End User
10.5.6 Middle East and Africa: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Country
10.5.6.1 Middle East and Africa: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Country
10.5.6.2 South Africa: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.5.6.2.1 South Africa: Noninvasive Ventilation Masks Market Breakdown, by Product
10.5.6.2.2 South Africa: Noninvasive Ventilation Masks Market Breakdown, by Application
10.5.6.2.3 South Africa: Noninvasive Ventilation Masks Market Breakdown, by End User
10.5.6.3 Saudi Arabia: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.5.6.3.1 Saudi Arabia: Noninvasive Ventilation Masks Market Breakdown, by Product
10.5.6.3.2 Saudi Arabia: Noninvasive Ventilation Masks Market Breakdown, by Application
10.5.6.3.3 Saudi Arabia: Noninvasive Ventilation Masks Market Breakdown, by End User
10.5.6.4 United Arab Emirates: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.5.6.4.1 United Arab Emirates: Noninvasive Ventilation Masks Market Breakdown, by Product
10.5.6.4.2 United Arab Emirates: Noninvasive Ventilation Masks Market Breakdown, by Application
10.5.6.4.3 United Arab Emirates: Noninvasive Ventilation Masks Market Breakdown, by End User
10.5.6.5 Rest of Middle East and Africa: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.5.6.5.1 Rest of Middle East and Africa: Noninvasive Ventilation Masks Market Breakdown, by Product
10.5.6.5.2 Rest of Middle East and Africa: Noninvasive Ventilation Masks Market Breakdown, by Application
10.5.6.5.3 Rest of Middle East and Africa: Noninvasive Ventilation Masks Market Breakdown, by End User
10.6 South and Central America
10.6.1 South and Central America Noninvasive Ventilation Masks Market Overview
10.6.2 South and Central America: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.6.3 South and Central America: Noninvasive Ventilation Masks Market Breakdown, by Product
10.6.3.1 South and Central America: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Product
10.6.4 South and Central America: Noninvasive Ventilation Masks Market Breakdown, by Application
10.6.4.1 South and Central America: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Application
10.6.5 South and Central America: Noninvasive Ventilation Masks Market Breakdown, by End User
10.6.5.1 South and Central America: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by End User
10.6.6 South and Central America: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Country
10.6.6.1 South and Central America: Noninvasive Ventilation Masks Market – Revenue and Forecast Analysis – by Country
10.6.6.2 Brazil: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.6.6.2.1 Brazil: Noninvasive Ventilation Masks Market Breakdown, by Product
10.6.6.2.2 Brazil: Noninvasive Ventilation Masks Market Breakdown, by Application
10.6.6.2.3 Brazil: Noninvasive Ventilation Masks Market Breakdown, by End User
10.6.6.3 Argentina: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.6.6.3.1 Argentina: Noninvasive Ventilation Masks Market Breakdown, by Product
10.6.6.3.2 Argentina: Noninvasive Ventilation Masks Market Breakdown, by Application
10.6.6.3.3 Argentina: Noninvasive Ventilation Masks Market Breakdown, by End User
10.6.6.4 Rest of South and Central America: Noninvasive Ventilation Masks Market – Revenue and Forecast to 2031 (US$ Million)
10.6.6.4.1 Rest of South and Central America: Noninvasive Ventilation Masks Market Breakdown, by Product
10.6.6.4.2 Rest of South and Central America: Noninvasive Ventilation Masks Market Breakdown, by Application
10.6.6.4.3 Rest of South and Central America: Noninvasive Ventilation Masks Market Breakdown, by End User
11. INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies in Noninvasive Ventilation Mask Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. COMPANY PROFILES
12.1 Hamilton Medical AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 ResMed Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Fisher & Paykel Healthcare Corp Ltd
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Air Liquide Medical Systems
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Dragerwerk AG & Co KGaA
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Intersurgical Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 BMC Medical Co Ltd
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 DeVilbiss Healthcare LLC
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Armstrong Medical Ltd
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Koninklijke Philips NV
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Besmed Health Business Corp
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
12.12 Sleepnet Corporation.
12.12.1 Key Facts
12.12.2 Business Description
12.12.3 Products and Services
12.12.4 Financial Overview
12.12.5 SWOT Analysis
12.12.6 Key Developments
12.13 SunMed Group Holdings LLC ( AirLife)
12.13.1 Key Facts
12.13.2 Business Description
12.13.3 Products and Services
12.13.4 Financial Overview
12.13.5 SWOT Analysis
12.13.6 Key Developments
12.14 Dimar S.P.A.
12.14.1 Key Facts
12.14.2 Business Description
12.14.3 Products and Services
12.14.4 Financial Overview
12.14.5 SWOT Analysis
12.14.6 Key Developments
12.15 Hangzhou Formed Medical Devices Co., Ltd
12.15.1 Key Facts
12.15.2 Business Description
12.15.3 Products and Services
12.15.4 Financial Overview
12.15.5 SWOT Analysis
12.15.6 Key Developments
12.16 SURU INTERNATIONAL PVT. LTD.
12.16.1 Key Facts
12.16.2 Business Description
12.16.3 Products and Services
12.16.4 Financial Overview
12.16.5 SWOT Analysis
12.16.6 Key Developments
12.17 Medline Industries LP
12.17.1 Key Facts
12.17.2 Business Description
12.17.3 Products and Services
12.17.4 Financial Overview
12.17.5 SWOT Analysis
12.17.6 Key Developments
13. APPENDIX
13.1 Glossary of Terms
13.2 About The Insight Partners
